/ /

CLINICAL

February Clinical Considerations for NPs, PasIn our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
The truth about isotretinoinSince its introduction, isotretinoin has been reported to cause psychiatric problems or irritable bowel disease. Because different studies over the past 35 years do not support these claims dermatologists should not hesitate to prescribe this medication for their acne patients.
Links shown between rosacea, other diseasesThree studies point to links between rosacea and numerous systemic comorbid diseases.
Rosacea and gastro disorders possibly relatedBecause rosacea is an inflammatory disease there is scientific rationale for a possible association between it and other inflammatory diseases. A recent study demonstrates that rosacea patients have a greater percentage of gastrointestinal disorders than do controls and should be evaluated further if they present with GI symptoms. In such cases a systematic approach to the treatment of both conditions may be warranted.
New hope for eczemaThe US Food and Drug Administration (FDA) has announced its approval of a new, corticoid-sparing ointment to treat mild to moderate atopic dermatitis in pediatric patients aged 2 years and older.
New guidelines for early peanut exposureNew recommendations for infant exposure to peanuts to prevent peanut allergy address something many pediatricians have long suspected: Early exposure to peanuts, even in infants that have eczema, could prevent development of peanut allergy.
Updated guidelines for diagnosis, treatment of rosaceaA revised and updated set of criteria and treatment recommendations establishes a phenotype approach to diagnosing and classifying rosacea. This approach marks a transition from treating rosacea patients according to subtype. Global representation may identify research needed to determine whether rosacea is a global condition.
Guidelines recommend early peanut introductionExperts weigh in on what to know about the new addendum to the peanut allergy prevention guidelines.
RF microneedling applicationsOne dermatologists describes her success with radiofreqency microneedling to treat acne and acne scarring.
FDA approves corticosteroid-sparing topical option for eczemaThe FDA announced it has approved Eucrisa (Anacor Pharmaceuticals, crisaborole) ointment to treat mild to moderate eczema in patients two-years-of-age and older.

Poll

View Results